Background: Although cases of extreme jungle fever of vivax have been recorded, information on immunological and incendiary examples is scarce. In our current research, the immunological and incendiary status of cases of slight and extreme gut disease of vivax is contrasted, while examining the immunopathological cases of this infection. Methods and Results: Identification of cases of active and detached jungle fever was carried out in 2009 at the Mayo Hospital in Lahore. A total of 228 members participated in the investigation. Those participating in the study were distributed rendering to proximity of Plasmodium vivax disease inside four clusters: uncolored (n = 95), asymptomatic (n = 63), mild (n = 54) and severely contaminated by viva...
Vivax malaria was historically described as 'benign tertian malaria' because individual clinical epi...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Context: Plasmodium vivax is geographically widely distributed with up to 2.5 billion people at risk...
Background: Although cases of extreme jungle fever of vivax have been recorded, information on immun...
BACKGROUND: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
Despite clinical descriptions of severe vivax malaria cases having been reported, data regarding imm...
Background: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
Background: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
Background: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
p. 1-8Background: Despite clinical descriptions of severe vivax malaria cases having been reported, ...
Background: Unless there is an extreme case for each year in normal times, Plasmodium vivax is occas...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Homeostatic perturbation caused by infection fosters two major defense strategies, resistance and to...
Vivax malaria was historically described as 'benign tertian malaria' because individual clinical epi...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Context: Plasmodium vivax is geographically widely distributed with up to 2.5 billion people at risk...
Background: Although cases of extreme jungle fever of vivax have been recorded, information on immun...
BACKGROUND: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
Despite clinical descriptions of severe vivax malaria cases having been reported, data regarding imm...
Background: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
Background: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
Background: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
p. 1-8Background: Despite clinical descriptions of severe vivax malaria cases having been reported, ...
Background: Unless there is an extreme case for each year in normal times, Plasmodium vivax is occas...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Homeostatic perturbation caused by infection fosters two major defense strategies, resistance and to...
Vivax malaria was historically described as 'benign tertian malaria' because individual clinical epi...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Context: Plasmodium vivax is geographically widely distributed with up to 2.5 billion people at risk...